In this episode, host Shikha Jain, MD, speaks with Sadie Dobrozsi, MD, about the power of information in personalized oncology care, understanding the impacts of genetic testing and more.

• Welcome to another exciting episode of Oncology Overdrive 1:34
• About Dobrozsi 1:39
• The interview 2:03
• What was your path to this field of pediatric oncology, and how did you decide to focus on genetic testing? 2:33
• Can you talk about what it means to use genomics to optimize therapy and tailor precision medicine, and how you implement that in your work? 7:58
• Why is it so important to continue focusing on funding precision medicine as an advancement in cancer care? 10:34
• Can you talk about your work with BRCA research and how treatment and surgeries have evolved with our understanding of it? 14:30
• Jain and Dobrozsi on the importance of shared decision-making in oncology, and how genomics plays a role in that ongoing conversation. 20:18
• How do we navigate difficult conversations with increasingly younger patient populations, and why are we having these conversations more now than ever before? 23:55
• When it comes to genetic testing, how much knowledge is “good knowledge”? 27:05
• If someone could only listen to the last few minutes of this episode, what would you want listeners to take away? 34:31
• How to contact Dobrozsi 35:12
• Thanks for listening 35:39

Sadie Dobrozsi, MD, is a board-certified pediatric oncologist, a nationally recognized leader in complex care delivery, and the medical director of genetic testing and oncology imaging at Evolent, a leading specialty and primary care management company.

We’d love to hear from you! Send your comments/questions to Dr. Jain at oncologyoverdrive@healio.com. Follow Healio on X and LinkedIn: @HemOncToday and https://www.linkedin.com/company/hemonctoday/. Follow Dr. Jain on X: @ShikhaJainMD. Dobrozsi can be reached on LinkedIn or via email sdobrozsi@evolent.com.

Disclosures: Jain and Dobrozsi report no relevant financial disclosures.